40635_2017_155_MOESM1_ESM.docx (125.76 kB)
Additional file1: Table S1. of Whole blood microRNA markers are associated with acute respiratory distress syndrome
journal contribution
posted on 2017-08-30, 05:00 authored by Zhaozhong Zhu, Liming Liang, Ruyang Zhang, Yongyue Wei, Li Su, Paula Tejera, Yichen Guo, Zhaoxi Wang, Quan Lu, Andrea Baccarelli, Xi Zhu, Ednan Bajwa, B. Taylor Thompson, Guo-Ping Shi, David ChristianiStudy required risk factors for ARDS on admission to ICU [6]. Table S2. Demographic characteristics of MEARDS miRNA study cohorts (n = 529). Table S3. MicroRNA candidate screening in discovery study. Table S4. Diagnostic performance of sepsis, pneumonia, and miRNA biomarkers for ARDS. Figure S1. MEARDS cohort recruitment process. Figure S2. Sample A (A) and sample B (B) from two patients both showed strong correlations between duplicate samples on different chips and different profiling day in discovery study (R 2 = 0.99), indicating that detectable miRNAs (after meeting quality control criteria) are experimentally consistent. Figure S3. Sample duplicate consistency between discovery and validation phase (after meeting quality control criteria). The figure showed high correlation (R 2 = 0.90) between miRNA expression in discovery study and validation study. Figure S4. Gene set enrichment analysis of 22 candidate miRNAs. Seventeen of them found to be significantly overrepresented (FDR q < 0.001) in ARDS vs at-risk control. miR-181a, miR-92a, and miR-424 are among the top enrich score miRNAs. Figure S5. Post hoc power calculation of logistic regression was calculated using G power (3.1.9). Under the null hypothesis, we assume the odds ratio equals to 1.5 with total sample size of 156; thus, we have a power (1 − β error probability) of 0.79 to detect differentially expressed miRNAs. (DOCX 125 kb)